Caricamento...
Cost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer
BACKGROUND: Cetuximab and panitumumab are monoclonal antibodies targeting the epidermal growth factor receptor. Both drugs are active against RAS wild type metastatic colorectal cancer after chemotherapy failure, with similar efficacy and toxicity profiles. However, their cost and limited survival b...
Salvato in:
| Pubblicato in: | PLoS One |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Public Library of Science
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5389795/ https://ncbi.nlm.nih.gov/pubmed/28403233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0175409 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|